Retrospective Study of Reoperation After Primary Augmentation With NATRELLE® INSPIRA® Breast Implants
RANBI-I
1 other identifier
observational
330
1 country
17
Brief Summary
This study will evaluate the incidence of reoperations associated with the use of smooth and textured NATRELLE® INSPIRA® TruForm® 1 and TruForm® 2 devices in patients who have undergone primary breast augmentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2014
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 6, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJuly 25, 2016
July 1, 2016
1.5 years
May 6, 2015
July 22, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Reoperations of All Cause Following the Use of Smooth or Textured NATRELLE® INSPIRA® TruForm® 1 or TruForm® 2 Breast Implants
4 Years
Secondary Outcomes (6)
Incidence (by Product Type) of First Reoperation Following the Use of Smooth or Textured NATRELLE® INSPIRA® TruForm®1 or TruForm® 2 Breast Implants
4 Years
Reasons For Primary Augmentation
4 Years
Time From the Date of Implant Until First Reoperation
4 Years
Reasons For Reoperation Incidence
4 Years
Incidences of Implant Removal With Replacement
4 Years
- +1 more secondary outcomes
Study Arms (4)
NATRELLE® INSPIRA® TruForm® 1 (Smooth)
Subjects receiving primary breast augmentation with smooth NATRELLE® INSPIRA® TruForm® 1 breast implants
NATRELLE® INSPIRA® TruForm® 1 (Textured)
Subjects receiving primary breast augmentation with textured NATRELLE® INSPIRA® TruForm® 1 breast implants
NATRELLE® INSPIRA® TruForm® 2 (Smooth)
Subjects receiving primary breast augmentation with smooth NATRELLE® INSPIRA® TruForm® 2 breast implants
NATRELLE® INSPIRA® TruForm® 2 (Textured)
Subjects receiving primary breast augmentation with textured NATRELLE® INSPIRA® TruForm® 2 breast implants
Interventions
Surgical implant
surgical implant
surgical implant
Eligibility Criteria
Subjects that have undergone a primary breast augmentation for aesthetic reasons with NATRELLE® INSPIRA® TruForm® 1 or TruForm® 2 implant.
You may qualify if:
- Primary breast augmentation (either bilateral or unilateral) operated on by the investigating surgeon with an infra-mammary approach smooth or textured NATRELLE® INSPIRA® TruForm® 1 or 2 device
- Primary breast augmentation 2 to 4 years (24-48 months) prior to data collection
- Subfascial, submuscular, dual plane or subglandular implant placement
You may not qualify if:
- Breast augmentation for Poland Syndrome or amastia
- Breast reconstruction following mastectomy
- Revision or secondary breast reconstruction
- Non NATRELLE® INSPIRA® device implanted at initial breast augmentation
- Women diagnosed with breast disease considered to be pre-malignant or malignant prior to or at the time of primary breast augmentation
- Surgical procedures of the breast not related to the primary breast augmentation (e.g. excision of significant skin lesions or a biopsy) occurring prior to or at the time of primary augmentation that may adversely affect the aesthetic outcome in the opinion of the investigator
- Axillary or peri-areolar approach
- Mastopexy augmentation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allerganlead
Study Sites (17)
Banff Plastic Surgery
Banff, Alberta, T1L 1B7, Canada
Macleod Trail Plastic Surgery
Calgary, Alberta, T2H 0L8, Canada
Jonathan Toy
Edmonton, Alberta, T5M 327, Canada
Y.E.S MedSpa & Cosmetic Surgery Centre
Langley, British Columbia, V2Y 0C8, Canada
Institute of Cosmetic and Laser Surgery
Oakville, Ontario, L6J 7W5, Canada
Ottawa Plastic Surgery: Dr. Howard Silverman
Ottawa, Ontario, K1Z 8R9, Canada
Rice Cosmetic Surgery
Toronto, Ontario, M2J 1V1, Canada
Cosmedical Rejuvenation Clinic
Toronto, Ontario, M2P 2C2, Canada
Yorkville Institute of Plastic Surgery
Toronto, Ontario, M5R 2J3, Canada
SpaSurgica
Waterloo, Ontario, N2J 1M3, Canada
Centre de Medecine et de Chirurgie Ambulatoires Isomed
Boucherville, Quebec, J4B 7M6, Canada
CCPEM
Montreal, Quebec, H3G 1B9, Canada
Cosmedica
Pointe-Claire, Quebec, H9R 5N3, Canada
Clinique de Chirurgie Plastique et Esthétique de la Haute-Ville
Québec, Quebec, G1V 1R4, Canada
Sebastien Nguyen MD Inc.
Québec, Quebec, G1V 4M6, Canada
Cosmetic Surgery Clinic
Waterloo, Quebec, N2L 3S2, Canada
Sandra McGill MD Inc.
Westmount, Quebec, H3Z 1S3, Canada
Study Officials
- STUDY DIRECTOR
Medical Director
Allergan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2015
First Posted
May 8, 2015
Study Start
December 1, 2014
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 25, 2016
Record last verified: 2016-07